A U.S. health advisory committee, the Advisory Committee on Immunization Practices (ACIP), has released a 2023 recommendation for using the JYNNEOS vaccine. The guidance is for people aged 18 and older who are at risk of getting mpox during an outbreak. This is not a new research study but an official public health guideline based on a review of available evidence.
The report does not provide new data on how well the vaccine works or its safety in this specific situation. It does not describe the number of people involved or the specific outcomes that were reviewed to make this decision. The recommendation is meant to inform doctors and health departments.
Readers should understand this is a formal recommendation from experts, not a breaking news story about a new vaccine discovery. It confirms that health officials consider this vaccine an important tool for adults at risk during mpox outbreaks. The best step is to talk with a healthcare provider about personal risk and vaccine options if concerned about mpox.
